Show simple item record

Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.

dc.contributor.authorWadsley, J
dc.contributor.authorAinsworth, G
dc.contributor.authorCoulson, AB
dc.contributor.authorGarcez, K
dc.contributor.authorMoss, L
dc.contributor.authorNewbold, K
dc.contributor.authorFarnell, K
dc.contributor.authorSwain, J
dc.contributor.authorHoward, H
dc.contributor.authorBeasley, M
dc.contributor.authorWeaver, A
dc.contributor.authorWood, K
dc.contributor.authorMarshall, J
dc.contributor.authorGriffin, M
dc.contributor.authorPascoe, A
dc.contributor.authorDu, Y
dc.contributor.authorTaprogge, J
dc.contributor.authorFlux, G
dc.contributor.authorBrown, S
dc.coverage.spatialUnited States
dc.date.accessioned2023-11-30T11:13:14Z
dc.date.available2023-11-30T11:13:14Z
dc.date.issued2023-09-01
dc.identifier.citationThyroid, 2023, 33 (9), pp. 1119 - 1123en_US
dc.identifier.issn1050-7256
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/6079
dc.identifier.eissn1557-9077
dc.identifier.eissn1557-9077
dc.identifier.doi10.1089/thy.2022.0707
dc.identifier.doi10.1089/thy.2022.0707
dc.formatPrint-Electronic
dc.format.extent1119 - 1123
dc.languageeng
dc.language.isoengen_US
dc.publisherMARY ANN LIEBERT, INCen_US
dc.relation.ispartofThyroid
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.subjectHumans
dc.subjectIodine Radioisotopes
dc.subjectIodine
dc.subjectThyroid Neoplasms
dc.subjectAdenocarcinoma
dc.subjectAntineoplastic Agents
dc.titleResults of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.en_US
dc.typeJournal Article
dcterms.dateAccepted2023-09-01
dc.date.updated2023-11-30T11:11:23Z
rioxxterms.versionVoRen_US
rioxxterms.versionofrecord10.1089/thy.2022.0707en_US
rioxxterms.licenseref.startdate2023-09-01
rioxxterms.typeJournal Article/Reviewen_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/37565288
pubs.issue9
pubs.organisational-groupICR
pubs.organisational-groupICR/Primary Group
pubs.organisational-groupICR/Primary Group/ICR Divisions
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radioisotope Physics
pubs.organisational-groupICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radioisotope Physics/Radioisotope Physics (hon.)
pubs.publication-statusPublished
pubs.publisher-urlhttp://dx.doi.org/10.1089/thy.2022.0707
pubs.volume33
icr.researchteamRadioisotope Physicsen_US
dc.contributor.icrauthorTaprogge, Jan
icr.provenanceDeposited by Mr Arek Surman on 2023-11-30. Deposit type is initial. No. of files: 1. Files: wadsley-et-al-2023-results-of-the-sel-i-metry-phase-ii-trial-on-resensitization-of-advanced-iodine-refractory.pdf


Files in this item

Thumbnail
Name:
wadsley-et-al-2023-results-of- ...
Size:
145.9Kb
Format:
PDF
View/Open

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/